CN Patent

CN117677395A — 长效glp1/胰高血糖素受体激动剂的剂量方案

Assigned to Boehringer Ingelheim International GmbH · Expires 2024-03-08 · 2y expired

What this patent protects

本发明涉及一种长效GLP1/胰高血糖素受体激动剂的给药方案。根据所述给药方案，这样定义两次连续施用之间的间隔，使得所述激动剂在人体中的血浆半衰期与所述施用间隔之间的比率大于1。

USPTO Abstract

本发明涉及一种长效GLP1/胰高血糖素受体激动剂的给药方案。根据所述给药方案，这样定义两次连续施用之间的间隔，使得所述激动剂在人体中的血浆半衰期与所述施用间隔之间的比率大于1。

Drugs covered by this patent

Patent Metadata

Patent number
CN117677395A
Jurisdiction
CN
Classification
—
Expires
2024-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.